Tag: FDA

FDA: Fagron Sterile Services recalls three lots of succinylcholine

Editor's Note The Food and Drug Administration (FDA) on June 23 posted the recall by Fagron Sterile Services (Wichita, Kansas) of three lots of succinylcholine chloride 20 mg/mL 5 mL syringes because of microbial growth detected during a simulation of the manufacturing process. This is a secondary recall of products…

Read More

By: Judy Mathias
June 26, 2017
Share

FDA: Vascular Solutions recalls Venture Catheters

Editor's Note The Food and Drug Administration (FDA) on June 21 announced the recall by Vascular Solutions (Maple Grove, Minnesota) of its Venture Catheters. The recall was initiated because there is a risk of the catheter tip splitting or separating during use and entering the patient’s bloodstream. This can result…

Read More

By: Judy Mathias
June 22, 2017
Share

FDA: Alvogen recalls seven lots of clindamycin

Editor's Note The Food and Drug Administration (FDA) on June 16 announced the recall by Alvogen/Hospira Inc, a Pfizer company, of seven lots of Clindamycin Injection USP ADD-Vantage Vials. The recall was initiated because microbial growth was detected during a routine simulation of the manufacturing process, which represents the potential…

Read More

By: Judy Mathias
June 21, 2017
Share

FDA: Maquet/Datascope recalls certain Intra-Aortic Balloon Pumps

Editor's Note The Food and Drug Administration (FDA) on June 19 announced the recall by Maquet/Datascope (Fairfield, New Jersey) of its System CS100, CS100i, and CS300 Intra-Aortic Balloon Pumps. The recall also applies to System 98 or System 98XT IABP that was converted to a CS100i or CS 300 IABP.…

Read More

By: Judy Mathias
June 20, 2017
Share

FDA: Hospira recalls Sodium Bicarbonate, Quelicin, and Potassium Phosphates injections

Editor's Note The Food and Drug Administration (FDA) on June 16 announced the recall by Hospira, Inc, a Pfizer company, of the following: 42 lots of 8.4% Sodium Bicarbonate Injection, USP, 50 mL vials 5 lots of Neut (Sodium Bicarbonate 4% additive solution) 5 mL vials 5 lots of Quelicin…

Read More

By: Judy Mathias
June 19, 2017
Share

FDA issues Safety Alert for frameless stereotaxic navigation systems

Editor's Note The Food and Drug Administration (FDA) on June 15 issued a Safety Alert for frameless stereotaxic navigation systems because of navigational accuracy errors during surgical procedures. Some of these errors have led to patient deaths, serious or life-threatening injuries, and inaccurate, aborted, or prolonged surgical procedures. The FDA…

Read More

By: Judy Mathias
June 16, 2017
Share

FDA releases list of reusable devices requiring new validated IFU, validation data

Editor's Note The Food and Drug Administration (FDA) on June 9 released a list of reusable devices that will require new validated instructions for use (IFU) and validation data in premarket notifications regarding cleaning, disinfection, and sterilization. These actions are effective August 8, 2017. The list includes: Bronchoscopes (flexible or…

Read More

By: Judy Mathias
June 12, 2017
Share

FDA extends UDI compliance dates for Class I, unclassified devices

Editor's Note The Food and Drug Administration (FDA) has notified medical device labelers that the compliance dates for unique device identifier (UDI) requirements for Class I and unclassified medical devices has been extended from September 24, 2018, to September 24, 2020, and for direct mark requirements from September 24, 2020,…

Read More

By: Judy Mathias
June 12, 2017
Share

FDA: Class I recall of Zimmer Biomet implantable spinal fusion stimulators

Editor's Note The Food and Drug Administration (FDA) on May 30 identified the recall by Zimmer Biomet (Warsaw, Indiana) of its SpF PLUS-Mini and SpF XL IIB implantable spinal fusion stimulators as Class I, the most serious. The recall was initiated because of higher than allowed levels of potential harmful…

Read More

By: Judy Mathias
May 31, 2017
Share

FDA: Class I recall of HeartMate II LVAS Pocket System Controller

Editor's Note The Food and Drug Administration (FDA) on May 23 identified the recall by Abbott-Thoratec (Pleasanton, California) of its HeartMate II Left Ventricular Assist (LVAS) Pocket System Controller as Class I, the most serious. Abbott-Thoratec has receives 70 reports of incidents in which the controller malfunctions after an exchange,…

Read More

By: Judy Mathias
May 24, 2017
Share
Live chat by BoldChat